1996/01/01 by Caitlin A. Orsini, Leah M. Truckenbrod, Alexa-Rae Wheeler +1
Biochemistry, Genetics and Molecular Biology · Neuroscience · Psychology · Social Sciences · #Amygdala #Biology #Castration #Central nervous system #Cognition #Developmental psychology #Endocrinology #Family and Matrimonial Law #Gonadal hormones #Hormone #Human Rights and Immigration #Humanities #Labor Law and Work Dynamics #Neuroendocrine regulation and behavior #Neuroscience #Nucleus accumbens #Philosophy #Political science #Prefrontal cortex #Psychiatry #Psychology #Receptor Mechanisms and Signaling #Schizophrenia (object-oriented programming) #Stress Responses and Cortisol #Testosterone (patch)
paper · open access · doi:10.1016/j.beproc.2022.104663
published in Aranzadi social 200(4), 2873-2886 (Elsevier BV)
openalex publication_date 1996/01/01 · openalex created_date 2016/06/24 · openalex updated_date 2026/06/24
Men and women differ in their ability to evaluate options that vary in their rewards and the risks that are associated with these outcomes. Most studies have shown that women are more risk averse than men and that gonadal hormones significantly contribute to this sex difference. Gonadal hormones can influence risk-based decision making (i.e., risk taking) by modulating the neurobiological substrates underlying this cognitive process. Indeed, estradiol, progesterone and testosterone modulate activity in the prefrontal cortex, amygdala and nucleus accumbens associated with reward and risk-related information. The use of animal models of decision making has advanced our understanding of the intersection between the behavioral, neural and hormonal mechanisms underlying sex differences in risk taking. This review will outline the current state of this literature, identify the current gaps in knowledge and suggest the neurobiological mechanisms by which hormones regulate risky decision making. Collectively, this knowledge can be used to understand the potential consequences of significant hormonal changes, whether endogenously or exogenously induced, on risk-based decision making as well as the neuroendocrinological basis of neuropsychiatric diseases that are characterized by impaired risk taking, such as substance use disorder and schizophrenia.